𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

✍ Scribed by Zoli, W; Ricotti, L; Susino, M Dal; Barzanti, F; Frassineti, G L; Folli, S; Tesei, A; Bacci, F; Amadori, D


Book ID
110002517
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
96 KB
Volume
81
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Sequential chemotherapy in nonsmall-cell
✍ Anna Ceribelli; Maria S. Pino; Alain J. Gelibter; Michele Milella; Fabiana L. Ce πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Improving results in nonsmall‐cell lung cancer (NSCLC) will require the development of new drugs and strategies to combine available agents. On the basis of data indicating the activity of docetaxel as second‐line therapy, a Phase II study was conducted to evaluate the e